Correspondence 0001193125-23-001546 from BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: Jan. 4, 2023 · CIK: 0000811240 · Accession: 0001193125-23-001546
AI Filing Summary & Sentiment
File numbers found in text: 333-268528
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 4, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Jessica Ansart Re: BIOLASE, Inc. Registration Statement on Form S-1 File No. 333-268528 Acceleration Request Requested Date: January 5, 2023 Requested Time: 5:00 P.M., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BIOLASE, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-268528 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 5:00 P.M. Eastern Time, on January 5, 2023 or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. We would appreciated it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651. Very truly yours, /s/ Michael Carroll Michael Carroll Secretary BIOLASE, Inc. cc: John R. Beaver, Chief Executive Officer Jennifer Bright, Chief Financial Officer Michael Carroll, Secretary Beth Berg, Sidley Austin LLP Istvan A. Hajdu, Sidley Austin LLP David E. Danovitch, Sullivan & Worcester LLP Aaron M. Schleicher, Sullivan & Worcester LLP